Tango Therapeutics, Inc. (TNGX)
Develops cancer drugs targeting specific genetic mutations to treat patients who don't respond to standard treatments.
$26.65-0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+308.1%
The outlook
TNGX trades at $26.65 with strong analyst backing—all 12 covering analysts rate it Buy or better. The stock sits roughly three-quarters of the way up its 52-week range, though its position relative to short-term moving averages is mixed. Analysts' average price target implies substantial upside versus the current price.
What’s behind the score
Analyst consensusStrong Buy — 1.2 avg of 12 analysts
Price trendMixed vs its moving averages
52-week range73% of the way from its 52-week low to high
Price targetAvg target +66% vs current price
Analyst price target
~12-month · 12 analysts$44.33average target+66.4% vs now
Now $26.65
Low $24.00High $69.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$4.34B
52-wk high
$34.39
52-wk low
$5.77
50-day avg
$26.97
200-day avg
$17.08
Trailing P/E
—